RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review

RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review

The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin family that is overexpressed in several cancers. RAGE is highly expressed in the lung, and its expression increases proportionally at the site of inflammation. This receptor can bind a variety of ligands, inclu...

Full description

Bibliographic Details
Main Authors: Tabrez Faruqui, Mohd Sajid Khan, Yusuf Akhter, Salman Khan, Zeeshan Rafi, Mohd Saeed, Ihn Han, Eun-Ha Choi, Dharmendra Kumar Yadav
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
cancer
RAGE
RAGE inhibitor
targeted therapy
end products
Online Access:https://www.mdpi.com/1422-0067/24/1/266

Similar Items

Similar Items